Mr Stephen Carter, SUDA’s Executive Chairman, commented: “We are...

Mr Stephen Carter, SUDA’s Executive Chairman, commented: “We are delighted to have this patent application accepted in South Africa. It reinforces our proprietary position covering the oral spray delivery of s.i.l.d.e.n.a.f.i.l. for erectile dysfunction and pulmonary arterial hypertension. Both products are the subject of licensing discussions in various countries. With granted patents, the value of our novel oral sprays is significantly enhanced.”